You just read:

New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™

News provided by

Hospira, Inc.

10 Jun, 2015, 08:00 BST